Fibromuscular dysplasia in argentina. a registry from the secondary hypertension working group of the argentine society of hypertension (sahara-df). project protocol and preliminary results
Article Sidebar
Main Article Content
Abstract
In Argentina there are no epidemiological data regarding fibromuscular dysplasia. Building a National Registry may provide information leading to updated consensus and recommendations for a correct diagnosis, assessment and treatment. Data gathering for the Argentine Registry of Fibromuscular Dysplasia (SAHARA-DF) was initiated in October 2015. By 2019, 49 patients were confirmed (44 women, 38 hypertensives, age 45.3 ± 17.2 years, 12 with a neurological presentation). Twenty-two patients had multi-site vascular lesions, in spite of a diagnosis bias due to lack of supporting studies in almost half of the cases. The renovascular site was the most affected, followed by the carotid and iliac sites, and multifocal lesions were more frequent than unifocal (35 versus 14, respectively). Associated aneurysms were found in 13 cases, and arterial dissection in 4. Twenty-two renal angioplasties were performed, 14 with stent placement. In this preliminary study of an Argentinian population, the systemic nature of the disease is evidenced, and a call for action arises regarding the need for discussing the diagnostic algorithm and treatment method.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Persu A, Giavarini A, Touzé E, et al., ESH Working Group Hyper-tension and the Kidney. European consensus on the diagnosis and ma-nagement of fibromuscular dyspla-sia. J Hypertens. 2014; 32:1367-78.
Kim ESH, Olin JW, Froehlich JB, et al. Clinical manifestations of fibromuscular dysplasia vary by pa-tient sex:a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol. 2013; 62:2026-8.
Plouin P-F, Baguet J-P, Thony F, et al., ARCADIA Investigators. High Prevalence of Multiple Arterial Bed Lesions in Patients with Fibro-muscular Dysplasia:The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hyper-tension. 2017; 70:652-8.
Dyke CK, Calif RM. National and regional registries:what good are they? Eur Heart J. 2000; 21:1401-3.
Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019; 24(2):164-89.
Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia:results in the first 447 patients. Circulation. 2012; 125:3182-90.
Wang LC, Scott DJ, Clemens MS, et al. Mechanism of Stent Failure in a Patient with Fibromuscular Dyspla-sia following Renal Artery Stenting. Annals of Vascular Surgery. 2015; 29:123.e19-123.e21.
Raju MG, Bajzer CT, Clair DG, et al. Renal artery stent fracture in pa-tients with fibromuscular dysplasia:a cautionary tale. Circ Cardiovasc Interv. 2013; 6:e30-1.
Joux J, Chausson N, Jeannin S, et al. Carotid-bulb atypical fibromus-cular dysplasia in young Afro-Ca-ribbean patients with stroke. Stroke. 2014; 45:3711-3.
Maas AHEM, Bouatia-Naji N, Persu A, et al. Spontaneous coronary artery dissections and fibromuscular dysplasia:Current insights on patho-physiology, sex and gender. Int J Cardiol.2019; 286:220-5.
Talarowska P, Dobrowolski P, Klisiewicz A, et al. High inciden-ce and clinical characteristics of fibromuscular dysplasia in patients with spontaneous cervical artery dissection:The ARCADIA-POL study. Vasc Med. 2019; 24(2):112-9.
Henrard C, Belge H, Fas-tré S, et al. Cervical artery dissection:fibromuscular dysplasia versus vascular Ehlers-Danlos syn-drome. Blood Press. 2019; 28:139-43.
O’Connor S, Kim ES, Brinza E, et al. Systemic connective tissue features in women with fibromus-cular dysplasia. Vasc Med. 2015; 20:454-62.
Farkašová Iannaccone S, Vasovčák P, Sopková D, et al. Arr-hythmogenic Ventricular Cardiom-yopathy Associated With Fibromus-cular Dysplasia of Ostial Right Main Coronary Artery. Am J Forensic Med Pathol. 2019. doi:10.1097/PAF.0000000000000469.
Krittanawong C, Kumar A, Johnson KW, et al. Prevalence, Presentation, and Associated Con-ditions of Patients With Fibromus-cular Dysplasia. Am J Cardiol. 2019; 123:1169-72.
Shoja T, Basman C, Jain S, et al. Postpartum Sudden Cardiac Death After Spontaneous Coronary Artery Dissection in a Patient With Fibro-muscular Dysplasia. Cardiol Res. 2017; 8:327-30.
Vance CJ, Taylor RN, Craven TE, et al. Increased prevalence of pree-clampsia among women undergoing procedural intervention for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2015; 29:1105-10.
Cunningham TK, Draper H, Ra-jesh U. Management of a pregnancy with underlying fibromuscular dys-plasia with a history of stroke and carotid artery dissection. J Obstet Gynaecol. 2019; 39(3):417-9.
Dobrowolski P, Januszewicz M, Klisiewicz A, et al. Echocardiogra-phic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia:the ARCADIA-POL study. J Hypertens. 2018; 36:1318-25.
Ganesh SK, Morissette R, Xu Z, et al. Clinical and biochemical pro-files suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J. 2014; 28:3313-24.
Di Monaco S, Georges A, Lenge-lé J-P, et al. Genomics of Fibromus-cular Dysplasia. Int J Mol Sci 2018; 19. doi:10.3390/ijms19051526